FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: Cells regulate the nucleation of microtubule polymerization locally and temporally, which is translated into accurate organization of the microtubule cytoskeleton, crucial for proper cell function. It...
2022-09-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: Intrinsically disordered regions (IDRs) are pervasive in eukaryotic proteomes despite their poor evolutionary conservation. IDRs have recently gained considerable interest as drivers of the formation...
2022-08-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: Cell types with distinct functions coexist and cooperate within a single animal, eventually contributing to the endless forms most beautiful that define the animal kingdom. These cell types are comple...
2022-04-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: Addressing the increased need for innovative solutions in medicine and healthcare, as we are witnessing during the current worldwide pandemic, requires more than ever the rise of the unique profession...
2022-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un AEI: EL SINDROME DE DOWN (SD) ES UN TRASTORNO DEL DESARROLLO CAUSADO POR LA PRESENCIA DE UNA COPIA ADICIONAL DEL CROMOSOMA 21 HUMANO (HSA21) Y SE CARACTERIZA POR DIVERSAS PARTICULARIDADES FISICAS Y NEUROLO...
2022-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un FP7: Lung diseases are a leading cause of mortality worldwide. Dysregulation of immunomodulatory molecules plays a key role in many pulmonary diseases, including lung cancer, idiopathic pulmonary fibrosis...
2021-11-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un H2020: In the EU alone, according to the Orphanet DB (https://pubmed.ncbi.nlm.nih.gov/31527858/), 30 million persons, 3,5-6% of the general population, are affected by one of the 6,172 different rare disease...
2021-10-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: In the last decade, basic and translational research dramatically expanded the development of new drug and regenerative therapies. Nevertheless, numerous potential therapies end up in the valley of de...
2021-09-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un FP7: We are in the midst of a revolution in our understanding of the internal organization of cells. In the 1950s we learned that lipid bilayer-based membranes serve as containers (organelles) within the...
2021-09-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un H2020: Understanding the interplay between animals and microorganisms associated with them has been recognised as an essential step for improving animal health, welfare and production. To understand the biom...
2021-09-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un FP7: Neural microexons are a paradigmatic example of a cell type-specific transcriptomic program. Microexons are tiny exons that we revealed to have striking neuronal specificity established by their maste...
2021-07-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un FP7: Cellular and sub-cellular organisation at the micrometre length scale ultimately reflects the activity of molecular networks that harness chemical energy to perform precise mechanical work, create fun...
2021-07-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un H2020: The creation of a European Health Data Space is one of the six strategic priorities for the newly elected European Commission. The European Health Research and Innovation Cloud (HRIC) will be one of t...
2021-03-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un H2020: The goal of PrecisionTox is to advance safety assessment of chemicals without the use of animal testing by establishing a new, 3Rs-compliant, cost-effective testing paradigm for chemical safety assess...
2021-02-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA participó en un H2020: The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) unites 49 partner organisations and institutions across Europe, including the major European advanced therapies le...
2021-02-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un H2020: PROTrEIN is a Training Network composed of 11 beneficiaries, and 8 partner organizations, from the academic and non-academic sectors with the mission to train a new generation of specialized bioinform...
2021-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un FP7: The goal of my research is to understand mutations and how they interact to alter phenotypes and disease. We recently initiated a new research direction that uses systematic (‘deep’) mutagenesis to qu...
2021-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un AEI:
2021-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un AEI:
2021-01-01 | Financiado

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un AEI:
2021-01-01 | Financiado